Documents

Revenue and net profit rose strongly year-over-year, with all segments posting double-digit growth.

Revenue up 10.92% but net profit down 59.42% amid high R&D and impairment losses.

Q3 net profit jumped 72.7% year-over-year, but nine-month net profit fell 22.7%.

Net profit dropped 44% despite revenue growth, as inventory impairment and subsidy cuts weighed.

Gross margin rose despite a 15.55% net profit drop, with sequential profit recovery evident.

2024 revenue rose modestly, but net profit dropped 20% due to margin pressure and restructuring.

Net profit dropped over 34% year-over-year amid margin pressure and rising R&D costs.

Net profit dropped 22.5% on stable revenue as gross margin declined sharply year-over-year.